My bookmarksSign up free

Commission Regulation (EU) No 1135/2014 of 24 October 2014 on the authorisation of a health claim made on foods and referring to the reduction of disease risk Text with EEA relevance

Commission Regulation (EU) No 1135/2014 of 24 October 2014 on the authorisation of a health claim made on foods and referring to the reduction of disease risk Text with EEA relevance

Regulation (EU) No 1135/2014 Β· Regulation Β· 3 articles

Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β†—

Article 1

1.Β Β Β The health claim listed in the Annex to this Regulation may be made on foods placed on the Union market in compliance with the conditions laid down in that Annex. 2.Β Β Β The health claim referred to in paragraph 1 shall be included in the Union list of permitted claims as provided for in Article 14(1) of Regulation (EC) No 1924/2006.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

PERMITTED HEALTH CLAIM

ANNEXSupplementary provisions

ANNEX PERMITTED HEALTH CLAIM Application β€” Relevant provisions of Regulation (EC) No 1924/2006 Applicant β€” Address Nutrient, substance, food or food category Claim Conditions of use of the claim Conditions and/or restrictions of use of the food and/or additional statement or warning EFSA opinion reference Article 14(1)(a) health claim referring to a reduction of a disease risk Rank Nutrition Ltd, Long Barn, Etchden Court, Bethersden, Kent, TN26Β 3DP, United Kingdom. Folic acid Supplemental folic acid intake increases maternal folate status. Low maternal folate status is a risk factor in the development of neural tube defects in the developing foetus. The claim may be used only for food supplements which provide at least 400 ΞΌg of folic acid per daily portion. Information shall be provided to the consumer that the target population is women of child-bearing age and the beneficial effect is obtained with a supplemental folic acid daily intake of 400 ΞΌg for at least one month before and up to three months after conception. Β  Q-2013-00265

Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next